Antidiabetic

Ertugliflozin

SGLT-2 inhibitor for T2DM as monotherapy or combination

About Ertugliflozin

Ertugliflozin is an active pharmaceutical ingredient (API) classified under the Antidiabetic category. SGLT-2 inhibitor for T2DM as monotherapy or combination

Medical Use

SGLT-2 inhibitor for T2DM as monotherapy or combination

Find Manufacturers in India

Pharmazon connects you with verified, GMP-certified pharmaceutical manufacturers who use Ertugliflozin in their formulations. Browse verified suppliers, compare product catalogs, and request quotes directly.

Find Ertugliflozin Manufacturers